Bone Growth Stimulator Market to Reach $2.55 bn by 2028; Launch of STIM onTrack Mobile App Version 2.1 by Orthofix to Aid Market Growth

The global bone growth stimulator market size is expected to hit USD 2.55 billion by 2028. The growing adoption and demand for bone morphogenetic proteins and platelet-rich plasma can have an outstanding effect on the market growth during the forecast period, states Fortune Business Insights, in a report, titled “Bone Growth Stimulator Market Size, Share & COVID-19 Impact Analysis, By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)); By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures, and Others) and By End-user (Hospitals & ASCs, Speciality Clinics, Home Care and Others) and Regional Forecasts, 2021-2028.” the market size stood at USD 1.75 billion in 2020 and is expected to exhibit a CAGR of 4.8% between 2021-2028.

Deferring elective surgical care has resulted in a substantial backlog of future patient demand during the COVID-19 pandemic. According to a study published in the Journal of Bone and Joint Surgery in May 2020, the United States could face a cumulative backlog of more than a million-spine surgery and joint replacement cases by the middle of 2022, and it will take the country up to 16-18 months to clear the backlog of orthopaedic care. As a result, it's possible that the massive backlog of orthopaedic surgeries throughout the world may help drive market growth in the near future.

Acquisition of Stimgenics by Medtronic to Consolidate Business

Stimgenics, LLC, a privately held business situated in Bloomington, Illinois, has pioneered a unique spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTMTM) Spinal Cord Stimulation, according to Medtronic plc. The treatment, which is provided through the Medtronic IntellisTM platform, is a novel programming option for treating chronic pain sufferers. The results of a three-month randomized control trial (RCT) comparing DTM to traditional SCS will be presented at the North American Neuromodulation Society (NANS) 23rd Annual Meeting in Las Vegas on January 23-26. The acquisition will create lucrative opportunities for the market. DTM waveform can activate a new mechanism that affects both neurons and glial cells, adding to our knowledge of SCS action mechanisms. When compared to either low frequency or high frequency alone, the DTM waveform has shown a statistically significant reversal of pain responses in animal models.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/bone-growth-stimulators-market-100161

Introduction of Innovative Products by Major Brands to Foster Growth

Increasing efforts from various manufacturers to produce unique and creative technologically advanced items would help the sector grow considerably. For example, Bioventus LLC released EXOGEN, an ultrasonic bone healing stimulator system, in Saudi Arabia in March 2016. Non-unions, delayed unions, and joint fusion are all treated with this product. In February 2020, Orthofix announced that the STIM onTrack mobile app version 2.1 had been approved by the US Food and Drug Administration (FDA) for use with the Company's bone growth stimulators.

Orthofix Holdings, Inc. to Dominate the Market

Orthofix Holdings, Inc. has gained FDA and CE certification for its CervicalStim and SpinalStim bone stimulators, which is expected to improve its global market position. Stryker, Medtronic, Bioventus, DJO, LLC, and a few more companies compete in the worldwide bone growth stimulator industry. These businesses compete in a fiercely competitive market.

Notable Development:

• March 2021: Bioventus LLC signed an agreement to acquire Bioness, inc. This will push Bioventus LLC to expand its bone growth therapy product portfolio.

The Report Lists the Key Companies in the Market:

• Orthofix Holdings, Inc. (Texas, U.S.)


• Zimmer Biomet (Warsaw, U.S.)


• Depuy Synthes. (New Brunswick, U.S.)


• Stryker (Kalamazoo, U.S.)


• Bioventus LLC. (North Carolina, U.S.)


• Medtronic Plc (Dublin, Ireland)


• DJO, LLC. (California, U.S)


• Arthrex, Inc. (Florida, U.S.)


• Terumo Corporation (Tokyo, Japan)

Further Report Findings:

• Regional Insights: Though North America is leading the market, Asia Pacific bone growth stimulators market share is expected to develop at a healthy rate during the forecast period. The region's profitable expansion is attributable to the growing frequency of bone disorders in the area. The large prospective patient pool, along with the market's under-penetration, could provide profitable growth possibilities for bone stimulator businesses looking to expand in the region and boost regional growth.


• Leading Segment: The market was controlled by the hospital segment, accounting for the maximum market share in 2020. The huge frequency of patient visits and orthopaedic operations performed in hospital facilities is the reason for its dominance.

The Market is Segmented into: